and then propose a robust association test procedure for GWAS that incorporates information from the extended HWD trend test into the GA trend test. Results and Conclusions: Our simulation studies and application of our method to a GWAS data set indicate that our proposed method can achieve the purpose described above.
Introduction
In genome-wide association studies (GWAS) with case-control designs, population stratification can happen when the participants are sampled from different subpopulations with significant allele frequency differences [1] . Population stratification can be a confounding factor in the association test and may produce spurious associations if not properly corrected [2] [3] [4] . Many methods have been developed to correct for stratification in association studies [3, 5, 6] . One of the most widely used methods is the generalized Armitage (GA) trend test implemented in the software EIGENSTRAT that uses principal component analysis to correct for population stratification [3] . The GA trend test usually assumes that the underlying disease model is additive [3] . In this paper, we use 'GA trend test' to denote the GA trend test assuming an additive model. One of the advantages of the GA trend test is that when the underlying disease model is additive or multiplicative, it can have high power in detecting causal variants. However, when the underlying disease model is dominant or recessive, it can have low power.
Some association tests that are robust to different genetic models have been developed for homogenous populations [7] [8] [9] [10] . For example, the MAX3 test statistic [7, 8] uses the maximum of the three Armitage trend test statistics [11] that assume the additive, dominant and recessive model, respectively. MAX3 has been extended to use top principal components (PCs) of genome-wide genotypes as covariates to correct for stratification [12] . This extended MAX3 method is referred to as 'MAX3-PC' in this paper. However, MAX3-PC has 2 limitations: (1) compared to the GA trend test, when the underlying disease model is additive or multiplicative, MAX3-PC can have relatively lower power; and (2) it can be computationally intensive for GWAS, especially for data with more than 1,000,000 SNPs. Since the additive/multiplicative genetic model is often assumed and fits well for most identified genetic variants [13] , in this article, we intend to propose a computationally efficient method for GWAS that can maintain the power of the GA trend test under the additive and multiplicative models, while it has improved power over the GA trend test under the recessive and dominant models.
To achieve this goal, first, we extend the Hardy-Weinberg disequilibrium (HWD) trend test by Song and Elston [14] for homogenous populations to account for population stratification. The 'extended HWD trend test' can provide useful information under the dominant or recessive models which is different from that provided by the GA trend test. Second, for GWAS we apply the generalized sequential Bonferroni (GSB) procedure to incorporate information from the extended HWD trend test into the GA trend test. Simulation studies indicate that the proposed GSB procedure for GWAS can control the family-wise error rate (FWER) when stratification exists; it has comparable power to that of the GA trend test, when the underlying model is additive or multiplicative, and has higher power than the GA trend test when the underlying model is dominant or recessive. Simulation studies also indicate that MAX3-PC by So and Sham [12] has relatively lower power than the GA trend test and the proposed GSB procedure under the additive and multiplicative models. Finally, we applied our proposed method to 4 data sets provided by the Wellcome Trust Case-Control Consortium (WTCCC) [13] .
Methods
We first extend the HWD trend test by Song and Elston [14] to account for population stratification, and then propose a GSB procedure for GWAS that incorporates information from the extended HWD trend test into the GA trend test. In this study, we assume independence among markers and ignore the LD among markers in the GWAS data.
Extended HWD Trend Test
Assuming that cases and controls are sampled from the same general homogenous population, Song and Elston [14] T HWDTT asymptotically follows a standard normal distribution, and the square of the test follows the χ 2 distribution with 1 degree of freedom. The HWD trend test statistic, T HWDTT , can be used to test the association between a marker and a disease under the assumption that the Hardy-Weinberg equilibrium holds in the general population from which the cases and controls are sampled. Song and Elston [14] stated that the HWD trend test can automatically control for the genotyping errors, if the cases and controls are genotyped by the same methods at the same time, with the cases and controls randomized. However, a weakness of the HWD trend test is that it can have an inflated type I error rate when population stratification exists (see our simulation results below). Below we extend the HWD trend test to account for population stratification.
First, we assign the cases and controls in the data to K groups (or clusters) that correspond to K putative subpopulations. Specifically, we calculate the top PCs, e.g. the top 10 PCs, of the genome-wide genotypes and then apply a clustering algorithm, e.g. the k -means clustering algorithm [15] , to the top PCs to partition the individuals into K groups.
In order to determine the number of subpopulations ( K ), we use the fpc package (http://cran.r-project.org/web/packages/fpc/ index.html) that implements the k -means clustering algorithm with options to determine the optimal number ( K ) of clusters [16] . More specifically, the fpc package uses the Duda-Hart test [17] to test if all individuals in the data are from one cluster. If they are not from one cluster, then the k -means clustering algorithm is executed with the cluster numbers k = 2, 3, …, K max (we set K max = 4 in our data analysis). The Calinski-Harabasz criterion is used to determine the optimal number of clusters from 2 to K max [18] . The Calinski-Harabasz criterion can be calculated as:
where SSW is the sum of variances within the clusters, SSB is the sum of variances among the clusters, and N is the number of individuals in the case-control data. The number of subpopulations is selected as:
For the cases and controls assigned to the i-th group where i = 1, 2, …, K , we define an effect size to be the difference (Δ i ) of the HWD coefficients between cases and controls:
control , and we denote its maximum likelihood estimation by β i = Δ i . Under H 0 , the Hardy-Weinberg equilibrium holds in the i -th subpopulation (corresponding to the i -th group) and the test marker is not associated with the disease, the variance of the estimated effect, Var H 0 (Δ i ), can be estimated (see Song and Elston [14] 
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Under H 0 that the Hardy-Weinberg equilibrium holds in each of the subpopulation and the test marker is not associated with a disease, the extended HWD trend test statistic is then defined as E 2 / V , which has an approximate χ 2 distribution with 1 degree of freedom.
GA Trend Test
To effectively control false positive rates caused by population stratification, Price et al. [3] proposed the GA trend test, which is implemented in the software EIGENSTRAT. The GA trend test calculates the top PCs from genome-wide genotype values for each individual. To test the association between a marker and the disease status, the GA trend test adjusts the individual's genotype value (assuming an additive model) at the marker by regressing out the top L PCs (e.g. L = 10) in a linear model (see Price et al. [3] ) and then adjusts the phenotypic value (0 for a control and 1 for a case) of the same L PCs in a similar way. The GA trend test statistic is defined as ( N -L -1 ) R 2 , where R 2 is the correlation between the ancestry-adjusted genotype and ancestry-adjusted phenotype, and N is the number of individuals in the case-control study. Under H 0 that the test marker is not associated with the disease, the GA trend test statistic asymptotically follows the χ 2 distribution with 1 degree of freedom.
GSB Procedure for Multiple Testing
For testing multiple hypotheses, H 1 , H 2 , …, H m , Holm [20] proposed a GSB procedure by assigning different weights to hypotheses of different importance. Let α denote the nominal FWER, which is defined as the probability of rejecting at least 1 true null hypothesis. We describe the GSB procedure below.
Let 
, so that w (1) , w (2) , …, w (m) and H (1 ) , H (2) , …, H (m) are the corresponding weights and hypotheses of the ordered B values. Starting from i = 1, given H (1) , H (2) , …, H (i -1) have been tested and rejected, if
, and stop the GSB procedure. Holm [20] proved that the GSB procedure controls the FWER at the nominal significance level α , if the condition that the weights are independent of the m tests is satisfied. From the proof by Holm [20] , we can see that the GSB procedure is relatively conservative and that the condition that the weights are independent of the m tests is a sufficient condition but not a necessary condition. We will show by simulation studies (see Appendix) that in some situations, even though the weights are weakly correlated with the m tests, the GSB procedure can still control the FWER well. In addition, from the rejection criterion above, in order to reject hypothesis H (i) , the corresponding p value p (i) must be less than or equal to α , otherwise the GSB procedure will not reject hypothesis H (i) .
We note that when the GSB procedure by Holm is applied to test the association at genome-wide markers, it cannot provide a p value for each marker, which may be needed when comparing the GSB procedure with other methods in real data analysis. Therefore, we define the adjusted p value for each test in the GSB procedure, following the idea of Westfall and Young [ 21 , p. 64 
be the adjusted p value corresponding to B (i) and Any adjusted p value greater than 1.0 should be set to 1.0. The adjusted p values should be compared to the nominal level α for the entire test procedure: if an adjusted p value is less than or equal to α , then reject the corresponding hypothesis.
GSB Procedure for GWAS Using Case-Control Data with Population Stratification
Here we describe how to apply the GSB procedure for multiple testing to GWAS data with population stratification. In the original GSB procedure, Holm [20] did not describe how to estimate the weights, although the GSB procedure has the potential to improve the power of multiple hypotheses testing when prior information is available to estimate the weights. Since the extended HWD trend test may provide different information from that provided by the GA trend test, we propose to use the extended HWD trend test to calculate a weight for each marker, and use the GA trend test to calculate a p value for the marker. Then we use the weight to adjust the GA trend test's p value in the GSB procedure. Specifically, let q i denote the p value for the i -th marker calculated by the extended HWD trend test. We let the weight w i for the i -th marker be the inverse of the extended HWD trend test p value q i , i.e. w i = 1/ q i . We then apply the GSB procedure to incorporate the weight into the corresponding GA trend test in GWAS.
As described in GSB Procedure for Multiple Testing, to reject H 0 that a marker is not associated with the disease, the p value from the GA trend test at that marker must be less than or equal to the nominal FWER α . This property can prevent that a null marker, which usually has a p value from the GA trend test greater than α (such as 0.05), is called significant because of the extremely high weight that is calculated from the extended HWD trend test due to genotyping errors.
The extended HWD trend test can have high power under both the recessive and dominant models, but it has no (or almost no) power under the multiplicative (or additive) model. Therefore, the weights calculated from the extended HWD trend test only generate noise when the underlying disease model is multiplicative or additive. This results in that under these 2 models, the GSB procedure (using p values from the GA trend test) has relatively lower power than the GA trend test (with Bonferroni correction) in GWAS. On the other hand, when the underlying disease models are recessive or dominant, weights calculated from the extended HWD trend test can provide useful information, and the GSB procedure can have much higher power than the GA trend test (see our simulation results below).
Since the additive model is often assumed in association studies in the literature when the true underlying genetic model is unknown, we hope to modify the GSB procedure for GWAS so that it can maintain the power of the GA trend test under the additive and multiplicative models, but still has increased power under the dominant and recessive models. To achieve this goal, we employ a smoothing method by Roeder et al. [22] to calculate smoothed weights. Suppose w i is the original weight for the i -th marker, w -is the average value of the weights for all markers. We calculate a smoothed weight for the i -th marker as w
, where λ is a parameter and 0 ≤ λ ≤ 1. We call the GSB procedure using the smoothed weights 'smooth-GSB procedure'. When λ is close to 1, then the smoothed weight is close to the constant w -, and the GSB procedure has similar results as the GA trend test. On the other hand, when λ is close to 0, the smoothed weight is close to the original weight w i , and the smooth-GSB procedure has similar results as the GSB procedure using the original weight w i . Since we hope that the smooth-GSB procedure has power close to that of the GA trend test in GWAS under the additive and multiplicative models, the value of λ should be close to 1. On the other hand, if λ is very close to 1, only a little information from the original weight (i.e. from the extended HWD trend test) can be used, this will result in that the smooth-GSB procedure does not have much increased power compared to the GA trend test under the recessive and dominant models. As a tradeoff, we would suggest the value of λ should be greater than 0.5 but less than 0.9.
In the GSB procedure for GWAS, if the weight calculated from the extended HWD trend test is (asymptotically) independent of the GA trend test at each marker, then the GSB procedure for GWAS can control the FWER. Joo et al. [23] proved that the HWD trend test statistic and the Cochran Armitage trend test statistic assuming the additive model are asymptotically independent in homogeneous populations. We expect that, as the extension of these 2 test statistics correcting for stratification, the extended HWD trend test statistic and the GA trend test statistic are approximately independent or at most are very weakly correlated. However, it is difficult to prove this independence theoretically. Below we will show by simulation studies that, at a marker, the correlation between the extended HWD trend test statistic and the GA trend test statistic is negligible. We will also show that in simulated case-control GWAS data, the GSB and smooth-GSB procedures can control the FWER.
Simulation Studies

Simulating Case-Control Data with Stratification
To evaluate the false positive rates and power of the extended HWD trend test and the proposed smooth-GSB procedure in case-control data with population stratification, we simulated data sets in a similar way to that in Price et al. [3] . Each data set was simulated to include 2,000 cases and 2,000 controls with 10,000 random SNPs. To simulate stratification, each individual was sampled from 1 of 2 populations. In the case group, 40% were sampled from population 1 and 60% were sampled from population 2. In the control group, 20% were sampled from population 1 and 80% were sampled from population 2. Allele frequencies for population 1 and population 2 at each of the 10,000 random SNPs were generated using the Balding-Nichols model with F ST = 0.01. Specifically, at each random SNP, the allele frequencies for populations 1 and 2 were each drawn from a beta distribution with parameters p (1 -F ST )/ F ST and (1 -p )(1 -F ST )/ F ST , where the ancestral population allele frequency p was sampled from the uniform distribution in the interval [0.1, 0.9]. Usually the allele frequency differences between populations 1 and 2 are less than 0.1 [3] . In addition to the 10,000 random SNPs, we simulated 10 SNPs with differential frequencies in populations 1 and 2. For each of these 10 SNPs, the allele frequency difference between populations 1 and 2 was greater than 0.1, to approximate the effect of selection. In our simulation, we set the allele frequency to 0.2 in population 1 and 0.8 in population 2 as a demonstration of strong selection. As an example, figure 1 shows the allele frequency differences at the 10,000 random SNPs between population 1 and population 2 in one replicate of our simulated data set. We can see that most of the allele frequency differences between the 2 populations are less than 0.1.
Type I Error Evaluation of the Original HWD Trend Test and the Extended HWD Trend Test
To compare the type I errors of the original HWD trend test by Song and Elston [14] and the extended HWD trend test, we chose a null SNP, i.e. a non-disease-causing SNP, from the simulated 10,000 plus 10 SNPs and evaluated the type I errors at this SNP. The null SNP was chosen in 2 ways: (1) from the 10,000 random SNPs and (2) from the 10 SNPs with differential frequencies, where we set the allele frequency as 0.2 in subpopulation 1 and 0.8 in subpopulation 2. We simulated 10,000 replicated data sets to estimate the type I error, the results of which are showed in table 1 . We can see that with the random null SNP, both the original HWD trend test and the extended HWD trend test could control the type I error well. However, at the SNP with highly differentiated allele frequencies in the 2 subpopulations, the original HWD trend test had an obviously inflated type I error rate and the extended HWD trend test could still control the type I error.
Evaluation of Correlation between the GA Trend Test and the Extended HWD Trend Test
We estimated the correlation coefficients between the GA trend test and the extended HWD trend test under H 0 that no markers are associated with the disease and that the Hardy-Weinberg equilibrium holds in each subpopulation. Under this H 0 , we generated 10,000 replicates of the case-control data with 10,000 plus 10 SNPs (see Simulating Case-Control Data with Stratification above). For each SNP, we calculated the GA trend test statistic and the extended HWD trend test statistic. The sample Spearman's rank correlation coefficient between the GA trend test and the extended HWD trend test was calculated for each SNP based on the 10,000 replicates. The mean and variance of the absolute values of Spearman's rank correlation coefficients for the 10,000 plus 10 markers were 0.00799 and 0.0060, respectively. These values indicate that the correlation between the 2 statistics is negligible.
FWER Evaluation
To evaluate the FWERs of our proposed GSB procedures, we generated 100,000 replicates of the case-control data (with 10,000 plus 10 SNPs) under H 0 that no SNPs are associated with the disease (see Simulating Case-Control Data with Stratification above). The FWER was estimated as the proportion of replicates with at least 1 false discovery. We also estimated the FWERs of the extended HWD trend test and the GA trend test. For these individual SNP-based tests, the significance level for individual SNPs was set using Bonferroni correction, i.e. the [12] .
Power Evaluation
To evaluate the power of the proposed methods, we simulated a causal SNP besides the 10,000 plus 10 noncausal SNPs as follows. At the causal SNP with allele A and B , let B denote the risk allele. We assume HardyWeinberg equilibrium in subpopulations 1 and 2. Suppose p k ( k = 1, 2) is the frequency of allele B in population k . The genotype frequencies of ( AA , AB , BB ) for controls (population control) of population k are set to
. Let the genetic relative risks be R 1 = Pr(affected| AB )/Pr(affected| AA ), R 2 = Pr(affected| BB )/ Pr(affected| AA ). When the genetic model is additive, multiplicative, dominant or recessive, we have R 2 = 2 R 1 -1, R 2 = R 1 2 , R 1 = R 2 , or R 1 = 1, respectively. The geno type frequencies of ( AA , AB , BB ) in cases is set to [(1 -
With the specified genotype frequencies, cases and controls were sampled from the corresponding trinomial distribution with parameters [(1 -
, respectively. We compared the power of 5 different methods: (1) the extended HWD trend test, (2) the GA trend test as implemented in EIGENSTRAT, (3) the GSB procedure, (4) the smooth-GSB procedure, and (5) MAX3-PC. The top 10 PCs of the genome-wide genotypes were used as covariates in the GA trend test and MAX3-PC. We simulated data under the 4 genetic disease models: the additive, multiplicative, dominant and recessive models; and we considered different genotype relative risks. For each scenario, we simulated 10,000 replicates of the case-control data. The nominal FWER was set to be 0.05. For the individual SNP-based tests (the extended HWD trend test, the GA trend test, and MAX3-PC), the corresponding significance level for each SNP was set to 0.05/ m , where m is the number of SNPs. The power was estimated as the proportion of replicates with identified significant SNPs.
To test the influence of different λ values on the smooth-GSB procedure, we estimated the power of the smooth-GSB procedure with different λ values ranging from 0.55 to 0.90 based on 10,000 replicated data sets. The results are reported in table 3 . We can see that the power of the smooth-GSB procedure is robust to different λ values when 0.55 ≤ λ ≤ 0.9. When λ increased from 0.55 to 0.90, the power of the smooth-GSB procedure slightly increased under the additive and the multiplicative models and slightly decreased under the dominant and recessive models. More specifically as λ increased from 0.60 to 0.85, the power increase of the smooth-GSB procedure under the additive and multiplicative models was usually less than 0.02, and the power decrease under the dominant and recessive models was usually less than 0.03. Given this, we would further suggest setting the λ value in the smooth-GSB procedure such that 0.60 ≤ λ ≤ 0.85. For example, we can set λ = 0.7. Compared to the GA trend test, our smooth-GSB procedure has much higher power under both the recessive and dominant models. On the other hand, the smooth-GSB procedure (when 0.60 ≤ λ ≤ 0.85) has power very close to the GA trend test (the difference is often less than 0.02) under both the additive and multiplicative models. For example, under the recessive model with genotype relative risk R 2 = 1.5, the power of the smooth-GSB procedure with λ = 0.6 was 0.531, which was about 10% (in absolute terms) higher than the power of the GA trend test (0.438). We can also see that the robust test MAX3-PC by So and Sham [12] had relatively lower power than the GA trend test and our smooth-GSB procedure under the additive and multiplicative models, while it had higher power than the other 2 methods under the dominant and recessive models. For example, under the additive model with genotype relative risk R 1 = 1.3, the power of the GA trend test, the smooth-GSB procedure (with λ = 0.6) and MAX-PC were 0.465, 0.448, and 0.420, respectively. The power of MAX3-PC was 4.5% (in absolute terms) lower than that of the GA trend test.
Another advantage of the smooth-GSB procedure is that it is much faster than MAX3-PC. On a computer with a 3.47-GHz CPU, with the PCs already computed, our R implementation of the smooth-GSB procedure for GWAS took less than 15 s to process 10,000 plus 10 SNPs, while MAX3-PC implemented in the robust SNP package [12] took about 1,100 s, if the absolute error of p values was set to 10 -6 . It took about 2,500 s, if the absolute error of p values was set to 10 -8 . This means that for GWAS with about 1,000,000 SNPs, MAX3-PC takes about 70 h with a p value accuracy level of 10 -8 , while the smooth-GSB procedure takes less than 25 min.
Application to WTCCC Data
The WTCCC data contain 7 different data sets of major diseases [13] . To evaluate the performance of our proposed method on real data, we chose 4 data sets from the WTCCC data: on bipolar disorder (BD), coronary artery disease (CAD), Crohn's disease (CD), and type 2 diabetes (T2D). Each of the 4 data sets has a reported genomic control inflation factor >1.06 [13] ; therefore, there may be population stratification in each of these data sets. There are about 3,000 controls and about 2,000 cases in each data set.
We did a quality control according to the description in the WTCCC paper [13] to filter out some individuals and SNPs. The total number of SNPs after the quality control was about 400,000. Following the suggestion of the WTCCC paper [13] , we used only 2 top PCs as covariates to correct for population stratification in the GA trend test and MAX3-PC. These PCs were calculated based on about 190,000 SNPs, which were obtained by pruning the whole genome SNPs using the software PLINK [24] . For each of the 3 single marker-based tests (the extended HWD trend test, the GA trend test and MAX3-PC), we can calculate a p value at each of the about 400,000 SNPs. But for the smooth-GSB procedure, we can only calculate an adjusted p value for each SNP (see GSB Procedure for Multiple Testing above). In order to compare the adjusted p value with the p values from the 3 single marker-based tests, we define a p value for each SNP in the smooth-GSB procedure as the adjusted p value divided by the number of tests ( m ); however, if the adjusted p value at a SNP is 1, then we will not define a p value for that SNP because H 0 will not be rejected at that SNP. When assuming the independence of markers, for the smooth-GSB procedure, comparing the adjusted p value with the nominal FWER α is equivalent to comparing the new defined p value with α/m . Following the suggestion of the WTCCC paper [13] , we used a threshold of 5 × 10 -7 for individual SNPs. Table 4 lists the significant SNPs identified by at least 1 of the 3 methods: the GA trend test, the smooth-GSB procedure, and MAX3-PC. For each significant region, only those SNPs with the smallest p value are listed. We can see that all SNPs detected by the GA trend test were also detected by the smooth-GSB procedure with different λ values: 0.6, 0.7, and 0.8; the only exception is SNP rs10761659 that was not identified by the smooth-GSB procedure with λ = 0.6 (p value = 5.01 × 10 -7 , which is very close to the threshold of 5 × 10 -7 ). For BD, SNP rs420259 was detected by both the smooth-GSB procedure and MAX3-PC, but not by the GA trend test. This is reasonable because the bestfitting genetic model for SNP rs420259 is recessive [13] . As we described earlier, the GA trend test has low power under the recessive model. In addition, 2 SNPs, rs11747270 (for CD) and rs10806665 (for T2D), and their corresponding regions were detected by both the GA trend test and the smooth-GSB procedure, but were not detected by MAX3-PC. The reason for this might be that the underlying disease models at these 2 SNPs are additive and MAX3-PC has relatively lower power than the other 2 methods under the additive model. We note that SNP rs10806665 (for T2D) was not identified as significant by the WTCCC paper [13] . We also note that for CAD, 2 SNPs, rs4854090 and rs5007171, were detected by MAX3-PC but not by the GA trend test and smooth-GSB procedure. The underlying disease models at these 2 SNPs might be recessive or [29] . Suppose there were 1,000 tests ( m = 1,000). For the j -th test, we simulated a pair of q and p values, q j and p j , from a bivariate uniform distribution with dependence between q j and p j by the Gaussian copula. We used Spearman's rank correlation coefficient ρ s to measure the dependency between the pair of q and p values ( q j and p j ). Once the pair of q and p values was simulated for each test, we had 1,000 pairs of q and p values corresponding to 1,000 tests. We calculated weights by using the q values, and then we applied the GSB procedure to the 1,000 tests. We replicated this simulation procedure 10 7 times and therefore generated 10 7 replicated 'data sets', each consisting of 1,000 pairs of q and p values. We estimated the FWER of the GSB procedure over these 10 7 replicated data sets with the nominal FWER of 0.01, 0.05 and 0.1. The FWER was estimated as the proportion of replicates with at least 1 false discovery. The results are showed in table 5 . From the results we can see that the FWER of the GSB procedure was well controlled when Spearman's rank correlation coefficient ρ s is ≤ 0.01 (i.e. the q and p values were weakly correlated).
